Suppr超能文献

中国多中心横断面观察性研究:2 型糖尿病老年患者甲状腺功能障碍的流行情况。

Prevalence of thyroid dysfunction in older Chinese patients with type 2 diabetes-A multicenter cross-sectional observational study across China.

机构信息

Peking University People's Hospital, Beijing, China.

General Hospital of Hebi Coal Industry [Group] Co., Ltd., Hebi, China.

出版信息

PLoS One. 2019 May 2;14(5):e0216151. doi: 10.1371/journal.pone.0216151. eCollection 2019.

Abstract

Type 2 diabetes [T2D] and thyroid dysfunction [TD] often co-occur, have overlapping pathologies, and their risk increases with age. Since 1995, universal salt iodization has been implemented in China to prevent disorders caused by iodine deficiency. However, after two decades of implementation of universal salt iodization, the prevalence of TD in elderly Chinese patients with T2D is not well described and may have been underestimated. We conducted a questionnaire-based survey across 24 endocrinology centers in China between December 2015 and July 2016. Demographic and clinical data from 1677 patients with T2D were obtained and analyzed to examine the prevalence of TD along with T2D in these patients. We assessed TD prevalence according to the four TD subtypes [subclinical hypothyroidism, clinical hypothyroidism, subclinical hyperthyroidism, and clinical hyperthyroidism], TD history, gender, and age. The diagnosis rates were calculated for TD and also for the TD subtype. The number of patients reaching treatment goals for T2D [hemoglobin A1c <7%] and TD [normal free thyroxine and thyroid-stimulating hormone [TSH]] and the incidences of complications and comorbidities were recorded. Among the enrolled patients with T2D [N = 1677], TD was diagnosed in 23.79% [399/1677] out of which 61% (245/399) were previously diagnosed and 38.59% (154/399) were newly diagnosed cases. Subclinical hypothyroidism, clinical hypothyroidism, subclinical hyperthyroidism, and clinical hyperthyroidism were reported in 4.89%, 9.3%, 1.13%, and 3.16% of the total population, respectively. Among patients previously diagnosed with TD, the incidence in women [166/795; 20.88%] was higher than in men [79/882; 8.96%]. The treatment goals for TD and T2D were attained in 39.6% [97/245] and 34.41% [577/1677] of the cases, respectively. Diabetic complications and comorbidities were reported in 99.7% of patients, with peripheral neuropathy being the most common [43.46%] followed by cataract [24.73%]. We had found that the incidences of dyslipidemia, elevated LDL levels, and osteoporosis were significantly higher in patients with TD than those without TD. TD is underdiagnosed in elderly Chinese patients with T2D.

摘要

2 型糖尿病 [T2D] 和甲状腺功能障碍 [TD] 常同时发生,具有重叠的病理特征,且其风险随年龄增长而增加。自 1995 年以来,中国一直在实施全民食盐碘化,以预防碘缺乏引起的疾病。然而,在实施全民食盐碘化二十年之后,中国老年 T2D 患者中 TD 的患病率尚不清楚,且可能被低估了。我们于 2015 年 12 月至 2016 年 7 月在全国 24 个内分泌中心进行了一项基于问卷的调查。我们获取并分析了 1677 例 T2D 患者的人口统计学和临床数据,以研究这些患者中 T2D 合并 TD 的患病率。我们根据四种 TD 亚型 [亚临床甲状腺功能减退症、临床甲状腺功能减退症、亚临床甲状腺功能亢进症和临床甲状腺功能亢进症]、TD 病史、性别和年龄评估 TD 的患病率。我们还计算了 TD 和 TD 亚型的诊断率。记录了达到 T2D [糖化血红蛋白 <7%] 和 TD [游离甲状腺素和促甲状腺激素正常]治疗目标的患者数量,以及并发症和合并症的发生率。在纳入的 T2D [N=1677]患者中,有 23.79% [399/1677]被诊断为 TD,其中 61%(245/399)为既往诊断,38.59%(154/399)为新诊断病例。亚临床甲状腺功能减退症、临床甲状腺功能减退症、亚临床甲状腺功能亢进症和临床甲状腺功能亢进症在总人群中的报告发生率分别为 4.89%、9.3%、1.13%和 3.16%。在既往诊断为 TD 的患者中,女性的发病率[166/795;20.88%]高于男性[79/882;8.96%]。TD 和 T2D 的治疗目标分别在 39.6% [97/245]和 34.41% [577/1677]的患者中达到。99.7%的患者报告了糖尿病并发症和合并症,其中周围神经病最常见[43.46%],其次是白内障[24.73%]。我们发现,TD 患者的血脂异常、LDL 水平升高和骨质疏松症的发生率明显高于无 TD 患者。在中国老年 T2D 患者中,TD 被严重漏诊。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8581/6497275/5c3e74bde29d/pone.0216151.g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验